clinical trial

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

clinical trial
Sep 13, 2024, 18:28 | Blog
Celebrating BattleCorn Care Packages gala and pediatric cancer research - Oncoheroes Biosciences
Oncoheroes Biosciences posted the following on LinkedIn: “We’re excited to share some incredible news! Oncoheroes…
Sep 11, 2024, 13:55 | Blog
Ana I. Velazquez Manana: Who benefits from adjuvant immunotherapy after neoadjuvant chemotherapy plus immunotherapy and surgery
Ana I. Velazquez Manana shared a post on X: ''Exploratory analysis comparing CM816 to CM77T…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 7, 2024, 07:38 | Societies
Yelak Biru: The inagural 5-night, 6-day Iceland Cycling Expedition
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, shared a post on…
Sep 5, 2024, 18:09 | Blog
How biomarkers can predict patients' responses to ICI treatments - CRI
CRI (Cancer Research Institute) shared a post on LinkedIn: ''Led by CRI Scientific Advisory Council…
Sep 1, 2024, 16:26 | Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 30, 2024, 16:19 | Blog
Mel Mann: 26 years since my life saving miracle
Mel Mann, Patient Advocate at Health Equity, Clinical Trials, Marrow Donation, shared a post on…
Aug 27, 2024, 17:43 | Insight
2nd trial for NET going into the world of CAR T-Cell
Lama Amer, Fellow at the University of Toronto, shared on X: "2nd trial for NET going…
Aug 22, 2024, 14:45 | Insight
Frances Ní Fhlannchadha: First time in Ireland a piece of research has been developed by patients for patients
Frances Ní Fhlannchadha shared a post on LinkedIn: "Well done, Siobhan Gaynor and Prof. Seamus…
Aug 22, 2024, 10:45 | Blog
Sharon Rivera Sanchez: Every day is a reminder that we are stronger together
Sharon Rivera Sanchez shared on LinkedIn: "Every day is a reminder that we are stronger…
Aug 16, 2024, 19:18 | Blog
Samuel Hume: The FDA approved 7 new drugs in June/July - what were they?
Samuel Hume, previous PhD at University of Oxford, shared on X: "The FDA approved 7…
Aug 8, 2024, 12:53 | Blog
How to interpret phase 3 cancer clinical trials hosted by Bishal Gyawal - Common Sense Oncology
Common Sense Oncology shared a post on X: ''Join us for a CSO lecture on…
Aug 3, 2024, 11:42 | Blog
Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
Ishwaria Subbiah shared a post on LinkedIn: "That's a wrap! July 2024 took me to…
Aug 2, 2024, 12:21 | Blog
Session Highlights on Irradiation Volume and SBRT Optimisation at ESTRO24
ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn: ''Comprehensive report on…
Jul 29, 2024, 21:01 | Blog
Wafik S. El-Deiry: My own experience with quinacrine
Wafik S. El-Deiry shared a post on X: ''Here is my own experience with quinacrine…
Jul 29, 2024, 07:08 | Blog
Idalid Franco: Great conference for all new investigators to attend
Idalid Franco shared a post on X: ''Final day of NRG Oncology 2024. Headed to…
Jul 28, 2024, 14:11 | Blog
Mark Lewis: Zebras need to find their herd
Mark Lewis shared a post on X: ''Zebras need to find their herd.  Honored to…
Jul 27, 2024, 22:06 | Blog
Codex Genetics's Annual Oncology Roundtable: Tackling Minimal Residual Disease and Complex Mutations
Codex Genetics shared a post on LinkedIn: ''Annual Oncology Roundtable: Tackling Minimal Residual Disease and…
Jul 26, 2024, 08:21 | Insight
William Rosa: Top Ten paper on what Palliative Care clinicians should know about interpreting a clinical trial
William Rosa, Palliative Care and Equity Researcher-Advocate at MSK Cancer Center, shared a post on X…
Jul 26, 2024, 03:26 | Insight
Exercise and biomarkers of early-stage prostate cancer - MSKCC
Memorial Sloan Kettering Cancer Center (MSKCC) shared a post on X: "A first of its…
Jul 25, 2024, 00:15 | Blog
FORTEe Newsletter: Summer 2024 Edition
FORTEe shared on X: "Check out our new FORTEe Newsletter: Summer 2024 Edition! Get the latest…
Jul 24, 2024, 02:33 | Insight
Hope in CAR-T Therapy: Promising Results in Incurable Pediatric Brain Cancer
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn…
Jul 21, 2024, 15:58 | Blog
Shushan Hovsepyan: Highlights from the ARST1431 study about treatment outcomes of RMS patients
Shushan Hovsepyan shared a post on LinkedIn: ''How can we better use molecular insights to…
Jul 21, 2024, 13:36 | Blog
Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint
Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…
Jul 20, 2024, 12:22 | Blog
EA2222/PUMP for patients with colorectal cancer liver metastases - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared a post on X: ''In clinical trial EA2222/PUMP, investigators are…
Jul 20, 2024, 10:32 | Blog
First patient dosed in Phase 1 trial of BTX-9341 - Biotheryx
Biotheryx shared a post on LinkedIn: ''We announced that the first patient has been dosed…
Jul 18, 2024, 22:40 | Blog
AI Prototype for ASCO24 by Brian Shields
Brian Shields, Creator of KOL Pulse AI, shared a post on LinkedIn: ''I'm working on…
Jul 18, 2024, 22:39 | Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 18, 2024, 09:04 | Blog
Bishal Gyawali: My thoughts on the NADINA trial
Bishal Gyawali shared a post on X: "My thoughts on the NADINA trial."  . Further…
Jul 17, 2024, 21:50 | Blog
Kimryn Rathmell: New cellular immunotherapy may be effective in treating metastatic solid tumors
Kimryn Rathmell shared a post on X: ''Hot off the press from Steven Rosenberg and…
Jul 17, 2024, 05:32 | Blog
EA3202 for Advanced Head and Neck Cancer
ECOG-ACRIN Cancer Research Group shared a post on X: "Clinical Trial EA3202, led by Aarti…
Jul 15, 2024, 21:23 | Insight
Zhuoer Xie: Risk Prediction for Clonal Cytopenia
Zhuoer (Zoey) Xie, Hematologist at Moffitt Cancer Center, shared on X about a recent paper…
Jul 15, 2024, 21:23 | Insight
Rizwan Romee: CAR memory–like NK cells targeting mesothelin show promise in ovarian cancer
Rizwan Romee, Associate Professor at Dana-Farber Cancer Institute, shared about a recent paper Mubin Tarannum…
Jul 15, 2024, 14:04 | Insight
Drew Moghanaki: RCT for oligoprogressive stage IV cancer leveraging “pulsed” SBRT
Drew Moghanaki shared on X: "NEW: phase II randomized clinical trial for oligoprogressive stage IV…
Jul 13, 2024, 18:24 | Blog
Eric Singhi: Advancing inclusion and diversity in clinical trial enrollment is essential for equitable care
Eric Singhi shared on X/Twitter: "Advancing inclusion and diversity in clinical trial enrollment is essential…
Jul 13, 2024, 14:15 | Dialogues
I never knew how close to this disease I would eventually become - Benny Johnson’s personal story with cancer
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr.…
Jul 13, 2024, 13:42 | Blog
Dr. Jay Spiegel received a $200K grant from The V Foundation to treat lymphoma
Sylvester Comprehensive Cancer Center shared on X: “Our very own Dr. Jay Spiegel received a…
Jul 13, 2024, 11:24 | Blog
Florian Lordick: The APGCC / SGCC Meet the Professors session
Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "Welcome to the APGCC /…
Jul 10, 2024, 05:38 | Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
Jul 8, 2024, 11:44 | Blog
The role of adjuvant chemotherapy and chemoradiation in Gallbladder cancers
Hepatobiliary and Retroperitoneal Sarcoma Division of Surgical Oncology at Tata Memorial Cancer Hospital made the following…
Jul 5, 2024, 13:47 | Insight
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Shilpa Gupta shared a post by Andrea Apolo, adding: "Huge congrats Andrea Apolo, leading this…
Jul 3, 2024, 23:45 | Insight
A four-patient trial testing a unique type of mRNA cancer vaccine - NCI
National Cancer Institute (NCI) shared a post on LinkedIn: "Recent results from several small clinical…
Jun 29, 2024, 16:09 | Blog
Daniel Stover: Real world studies versus negative clinical trials
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jun 29, 2024, 12:06 | Drugs
Injectable form of nivolumab vs the intravenous form against kidney cancer - NCI
National Cancer Institute (NCI) shared on X:  "In a Clinical Trial, an injectable form of…
Jun 28, 2024, 14:34 | Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn:   . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 02:53 | Blog
Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat
Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…
Jun 26, 2024, 11:01 | Blog
Cancer Research Institute's virtual Patient Immunotherapy Summit
Cancer Research Institute (CRI) shared on LinkedIn: ""I was one of the first lung cancer…
Jun 25, 2024, 16:01 | Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X:  . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 24, 2024, 23:11 | Blog
Chandler Park: Superb discussion of the TRANSMET study presented at ASCO24 by Cathy Eng
Chandler Park shared on X: “Dr. Cathy Eng provides a superb and thoughtful discussion of…
Jun 24, 2024, 16:55 | Blog
Laura Esfeller: It's World Kidney Cancer Day and the theme “We Need to Listen” really hits home
Laura Esfeller shared on X:                  . "Today’s…
Jun 20, 2024, 14:53 | Blog
Simple graphics to convey clinical trial information effectively - PRIMR
PRIMR shared on X/Twitter: "PRIMR uses simple graphics to convey clinical trial information effectively. The…
Jun 18, 2024, 04:01 | Blog
Matteo Lambertini: Great slide to explain type I and type II errors
Matteo Lambertini recently shared a post on X: "What a great slide to explain type…
Jun 16, 2024, 14:10 | Insight
Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24
Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…
Jun 16, 2024, 09:04 | Blog
The final day of the annual EORTC course
EORTC (European Organisation for Research and Treatment of Cancer) shared on LinkedIn:       …
Jun 14, 2024, 13:12 | Blog
Sharon Rivera Sanchez: I’m joining my fourth clinical trial since my cancer diagnosis
Sharon Rivera Sanchez, Breast and Colon Cancer Patient Advocate, CEO and Founder of Trials of…
Jun 13, 2024, 17:33 | Insight
Agenus' Phase 1 clinical trial results have been published in Nature
Agenus shared their publication on investigational immunotherapeutic agents in Nature: "Results from our Phase 1…
Jun 11, 2024, 15:36 | Blog
Jia Liu: Thrilled to share results from the Phase I/II clinical trial of dendrimer SN38
Jia Liu, Translational Lead, Early Phase Drug Development at The Kinghorn Cancer Centre and Conjoint…
Jun 11, 2024, 03:04 | Blog
Vijendra Singh: Why I'm skeptical about Imetelstat's use for MDS treatment
Vijendra Singh, Medical oncologist at Karmanos cancer center, shared a post on X/Twitter: ''Why I'm…
Jun 7, 2024, 09:11 | Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 6, 2024, 12:42 | Blog
Robert Daly: Thank you for the mentorship and collaboration of the MATCHES Center team
Robert Daly, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post by…
Jun 6, 2024, 10:31 | Blog
Laura Esfeller: What did ASCO24 mean to me as a patient advocate and cancer survivor?
Laura Esfeller shared a post on X: "What did ASCO24 mean to me as a patient…
Jun 6, 2024, 04:19 | Opinion
Roy Herbst shared the updated results from the COAST clinical trial - Yale Cancer Center
Yale Cancer Center shared a post on X: "Roy Herbst shared the updated results from…
Jun 2, 2024, 22:12 | Blog
Jacquelyne Gaddy non-genomic factors are likely the cause of outcome disparities in PDAC - Yale Cancer Center
Yale Cancer Center shared on X/Twitter: "Jacquelyne Gaddy presents research showing non-genomic factors are likely the…
Jun 2, 2024, 11:37 | Blog
Tarah Ballinger: Excited to present results of this trial focused solely on Black people with breast cancer at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a…
May 31, 2024, 10:51 | Blog
Yüksel Ürün on CheckMate 901 trial
Yüksel Ürün shared a post on X: "CheckMate 901 trial: Abstract #4509 For lymph node-only mUC,…
May 27, 2024, 12:39 | Societies
Selin Kurnaz: Massive Bio and Precision Cancer Consortium's collaborative abstract accepted at ASCO24
Selin Kurnaz, Co-Founder and CEO at Massive Bio, shared on LinkedIn: "I am beyond proud…
May 27, 2024, 07:37 | Blog
Eric K. Singhi on BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo in 1L ES-SCLC
Eric K. Singhi shared the following on X: “BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo…
May 27, 2024, 04:49 | Insight
Ben Westphalen: Revolutionary way of creating access to molecularly guided treatment options
Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO,  shared on…
May 26, 2024, 12:31 | Drugs
New way to fight low-grade gliomas in kids - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared on LinkedIn: “Exciting news in childhood brain tumor research! Thanks to…
May 25, 2024, 14:40 | Blog
Dr. Mark Ball on the future of kidney cancer treatment - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "CANCER CURRENTS: In a large clinical trial, treatment…
May 24, 2024, 14:22 | Blog
Ryan Moy: Our investigator-initiated trial for diffuse gastric cancer after progression on first-line therapy is now open at Columbia!
Ryan Moy, Assistant Professor of Medicine and Medical Oncologist at Columbia University Irving Medical Center,…
May 24, 2024, 14:15 | Blog
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X: “Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the…
May 24, 2024, 13:24 | Insight
Erman Akkus Summarizes 5-year Results of CheckMate 040
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…
May 23, 2024, 14:37 | Insight
Bishal Gyawali: Interesting study on survival outcomes for participants of clinical trials
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 22, 2024, 15:11 | Insight
Kimryn Rathmell: My editorial with Dr. Catherine Fahey highlighting a recent study by Dr. Joseph Unger
Kimryn Rathmell shared on X/Twitter: "A recent study by Dr. Joseph Unger, Fred Hutchinson Cancer Center +…
May 17, 2024, 12:54 | Insight
Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer
Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…
May 14, 2024, 09:21 | Drugs
Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer
Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…
May 13, 2024, 14:53 | Blog
Ruzanna Papyan: The life-saving potential of anti-GD2 therapy in treating high-risk neuroblastoma
Ruzanna Papyan shared the following on LinkedIn: ''Week 2 of the Global Access To AntiGD2…
May 13, 2024, 07:59 | Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 12, 2024, 13:31 | Blog
Stephen Liu: Update from phase 3 IMscin001 trial JTO and JTO CRR
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: “Update from…
May 11, 2024, 14:04 | Blog
Ishwaria Subbiah: A midnight session on cancer pain for Indonesia's expert oncologists and palliative care clinicians
Ishwaria Subbiah shared on LinkedIn: "Facilitating a midnight session (!) on cancer pain for 80 of…
May 11, 2024, 02:47 | Blog
Mel Mann: Gleevec’s Anniversary
Mel Mann, Patient Advocate in Oncology and cancer survivor, shared on LinkedIn: ''Gleevec’s Anniversary. On 10…
May 9, 2024, 00:21 | Blog
Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors
Enes Erul, Oncology Fellow at Ankara Üniversitesi, shared on X: “Trastuzumab deruxtecan shows promise in HER2-mutant…
May 9, 2024, 00:16 | Insight
Update CheckMate 9ER summarized by Sergio Cifuentes
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X: “Update CheckMate 9ER - PFS:…
May 8, 2024, 23:17 | Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 8, 2024, 00:09 | Blog
Bishal Gyawali: My journal club on DYNAMIC trial study
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 5, 2024, 12:04 | Blog
Piotr Wysocki: Elective Pelvic Lymph Node Radiation for elderly patients with prostate cancer
Piotr Wysocki recently shared on LinkedIn: "Sayan M et al. analyzed individual patient data from a…
May 3, 2024, 00:05 | Blog
Jeremy Teoh: ERBT could reduce the 1-year recurrence rate in NMIBC
Jeremy Teoh, Assistant Dean (External Affairs) & Associate Professor at CUHK Medicine, made the following…
May 2, 2024, 12:01 | Blog
Ramy Sedhom: In lockstep with the ASCO Presidential Theme - Palliative Care is on the stage as a plenary at this year's Annual Meeting
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, shared a post…
May 1, 2024, 12:17 | Insight
David R. Liu: The first prime editing clinical trial has been cleared by U.S. FDA to begin
David R. Liu, Core Institute Member and Vice-Chair of the Faculty at Broad Institute of MIT…
May 1, 2024, 12:12 | Blog
FDA has cleared Prime Medicine's PM359 for the treatment of chronic granulomatous disease
Prime Medicine shared on X/Twitter: "We are pleased to announce that FDA has cleared our IND…
Apr 29, 2024, 23:03 | Insight
Manni Mohyuddin: Aaron Goodman and I draw attention to over treatment of multiple myeloma and its precursor states
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Apr 29, 2024, 20:33 | Blog
Don't miss the TAPUR Study Virtual Grand Rounds on May 6 - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on LinkedIn: “"Don't miss the TAPUR Study Virtual Grand…
Apr 28, 2024, 11:19 | Blog
Paolo Tarantino: Truly groundbreaking work that turned a failed chemotherapy in one of the most active anticancer drugs ever developed
Paolo Tarantino shared a post by Florian Muller, Co-Head of Biology at Powder Gate Discovery, on…
Apr 27, 2024, 08:10 | Blog
Pam Mangat-Dhaliwal: Join us for a virtual Grand Rounds on May 6, 2024 to learn the latest from the TAPUR Study
Pam Mangat-Dhaliwal, Division Director of Clinical Research and Analytics at ASCO, shared on LinkedIn: “Join…
Apr 26, 2024, 19:38 | Opinion
Pedro C Barata: Our work on transcriptomic profiles in RCC
Pedro C Barata, Medical Oncologist at University Hospitals Seidman Cancer Center, posted on X/Twitter: "Happy…
Apr 26, 2024, 15:30 | Blog
Tatiana Prowell: We just lost one of the greats Sheila Johnson
Tatiana Prowell shared on X/Twitter: ''We just lost one of the greats, Sheila Johnson. A…
Apr 26, 2024, 10:07 | Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 26, 2024, 10:00 | Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
Apr 26, 2024, 09:41 | Blog
Vivek Subbiah: Read a recap of 'AI at the Interface' at AACR24 plenary session in AACR Annual Meeting News
Vivek Subbiah posted on X/Twitter: ''Yes! The future IS now! 'AI at the Interface: Accelerating…
12
All: 159 Posts: 1 - 100
Special Coverage